Shuna Luo Xiaofei Xu Xingnong Ye Xiaoqiong Zhu Cai Wu Dan Chen Jingxia Jin Yan Zheng Mengli Zheng Jian Huang
10.2147/OTT.S272207
Onco Targets Ther
2020 Oct 9;13:10143-10148.
kras decitabine myelodysplastic syndrome myeloproliferative neoplasm ruxolitinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33116596/
Case Reports
PMC7553600
33116596
Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS
2020